• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地西泮从空心型栓剂中的缓释

Enhanced release of diazepam from hollow-type suppositories.

作者信息

Kaewnopparat N, Kaewnopparat S, Rojanarat W, Ingkatawornwong S

机构信息

Prince of Songkla University, Hat-Yai, Songkla Thailand.

出版信息

Int J Pharm Compd. 2004 Jul-Aug;8(4):310-2.

PMID:23924703
Abstract

The objective of this study was to develop a rapid-release diazepam suppository. Four kinds of diazepam suppositories were formulated: (1) a conventional suppository with Witepsol H-15 as a base, (2) a conventional suppository with mixed polyethylene glycols as a base, (3) a hollow-type suppository with Witepsol H-15 as a base that contained diazepam solution in its cavity and (4) a hollow-type suppository with Witepsol H-15 as a base that contained diazepam powder in its cavity. The result of the differential scanning calorimetry thermograms indicated that diazepam dissolved in Witepsol base had a strong affinity to the lipophiic base while diazepam dispersed in polyethylene glycol base was still in the crystalline form. The release study of prepared suppositories showed that the release of diazepam from suppository 1 and suppository 4 was very slow. The diazepam released from suppository 2 after 5 minutes was about 30%. The diazepam released from suppository 3 after 5 minutes was about 85%, which was significantly faster than that of the other three formulations (1, 2, and 4). The hollow-type suppository that contained diazepam solution was found to be the most effective rapid-release formulation.

摘要

本研究的目的是研制一种速释地西泮栓剂。制备了四种地西泮栓剂:(1)以Witepsol H - 15为基质的常规栓剂;(2)以混合聚乙二醇为基质的常规栓剂;(3)以Witepsol H - 15为基质的中空型栓剂,其腔内含地西泮溶液;(4)以Witepsol H - 15为基质的中空型栓剂,其腔内含地西泮粉末。差示扫描量热法热谱图结果表明,溶解在Witepsol基质中的地西泮与亲脂性基质有很强的亲和力,而分散在聚乙二醇基质中的地西泮仍为结晶形式。对所制备栓剂的释放研究表明,栓剂1和栓剂4中地西泮的释放非常缓慢。栓剂2在5分钟后释放的地西泮约为30%。栓剂3在5分钟后释放的地西泮约为85%,明显快于其他三种制剂(1、2和4)。发现含有地西泮溶液的中空型栓剂是最有效的速释制剂。

相似文献

1
Enhanced release of diazepam from hollow-type suppositories.地西泮从空心型栓剂中的缓释
Int J Pharm Compd. 2004 Jul-Aug;8(4):310-2.
2
Pharmaceutical evaluation of hollow type suppositories. IV. Improvement of bioavailability of propranolol in rabbits after rectal administration.中空型栓剂的药学评价。IV. 普萘洛尔经直肠给药后家兔生物利用度的提高。
J Pharmacobiodyn. 1986 Jun;9(6):526-31. doi: 10.1248/bpb1978.9.526.
3
Difference in rectal absorption of morphine from hollow-type and conventional suppositories in rabbits.兔体内中空型与传统栓剂中吗啡直肠吸收的差异。
Biol Pharm Bull. 1993 Feb;16(2):150-3. doi: 10.1248/bpb.16.150.
4
[Controlled release of prednisolone from suppository prepared using powder of pulverized tablet].[用碾碎片剂粉末制备的栓剂中泼尼松龙的控释]
Yakugaku Zasshi. 2008 Apr;128(4):641-8. doi: 10.1248/yakushi.128.641.
5
Isoniazid release from suppositories compounded with selected bases.异烟肼从与选定基质混合的栓剂中的释放情况。
Int J Pharm Compd. 2007 Sep-Oct;11(5):433-7.
6
Release property of progesterone from a mixed-base suppository consisting of Witepsol W35 and Witepsol E85.黄体酮从由Witepsol W35和Witepsol E85组成的混合基质栓剂中的释放特性。
Drug Dev Ind Pharm. 2001 Nov;27(10):1039-45. doi: 10.1081/ddc-100108366.
7
Evaluation of sustained release suppositories prepared with fatty base including solid fats with high melting points.对用包括高熔点固体脂肪在内的脂肪基质制备的缓释栓剂的评价。
Int J Pharm. 2004 Jul 8;278(2):275-82. doi: 10.1016/j.ijpharm.2004.03.030.
8
Availability of oxyphenbutazone from different suppository formulations.
Pharmazie. 1980;35(4):213-6.
9
Novel chronotherapeutic rectal aminophylline delivery system for therapy of asthma.用于哮喘治疗的新型时辰治疗性直肠氨茶碱给药系统。
Int J Pharm. 2009 Sep 8;379(1):119-24. doi: 10.1016/j.ijpharm.2009.06.017. Epub 2009 Jun 23.
10
Utility of a rectal suppository containing the antiepileptic drug zonisamide.含抗癫痫药物唑尼沙胺的直肠栓剂的效用。
Biol Pharm Bull. 1997 Aug;20(8):892-6. doi: 10.1248/bpb.20.892.

引用本文的文献

1
Physiological and Pharmaceutical Considerations for Rectal Drug Formulations.直肠给药制剂的生理学和药学考量
Front Pharmacol. 2019 Oct 16;10:1196. doi: 10.3389/fphar.2019.01196. eCollection 2019.